Estriol/Estradiol [50%/50%] 0.05-0.5 mg/Gm/Progesterone 5-50 mg/Gm Topical Gel is a specially compounded medication. It is dispensed through a pump mechanism for easy and precise application. This semisolid formulation is designed for targeted treatment or absorption of active ingredients. It is used to treat conditions such as Vulvovaginal Atrophy, Menopausal Symptoms, Uterine Bleeding, Endometriosis, and Dyspareunia.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
This topical gel formulation is a compounded blend of estriol and estradiol, each constituting 50% of the formulation, with concentrations ranging from 0.05 to 0.5 mg/gm. It also contains progesterone in concentrations ranging from 5 to 50 mg/gm. This unique combination is designed to address a variety of health conditions, including menopausal symptoms, endometriosis, uterine fibroids, and premenstrual syndrome (PMS). It has also been found to potentially reduce the risk of endometrial cancer.
The gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The active ingredients are absorbed through the skin and into the bloodstream, providing targeted treatment. The gel-like consistency ensures a smooth application process.
It is crucial to note that this formulation is not suitable for pregnant women or women who are breastfeeding. The active ingredients may cause harm to the fetus or pass into breast milk, potentially causing harm to the infant.
When used as directed, this formulation has been shown to effectively alleviate symptoms such as hot flashes, night sweats, and vaginal dryness. It may also contribute to a reduced risk of developing endometrial cancer and uterine fibroids.
If you have any questions or concerns about this formulation, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is well-equipped with the knowledge and expertise to assist you.
This compounded formulation of Estriol/Estradiol [50%/50%] 0.05-0.5 mg/Gm/Progesterone 5-50 mg/Gm is a topical gel designed for precise application on the skin. It is primarily used for the treatment of menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. It can also be beneficial in treating vulvovaginal atrophy, a condition common in postmenopausal women due to decreased estrogen levels.
Additionally, this formulation may be used in the treatment of endometriosis, a condition where tissue that normally lines the uterus grows outside of it. Certain types of breast cancer in premenopausal women may also be treated with this formulation.
However, it is important to note that this formulation should not be used by women who are pregnant or breastfeeding. Women with a history of stroke, blood clots, or liver disease should also avoid using this product. If you are currently taking other medications, such as anticoagulants, it is crucial to consult your healthcare provider before starting this treatment.
The gel should be applied to the affected area once daily, or as directed by your healthcare provider. Exceeding the recommended dose may increase the risk of side effects.
Common side effects include skin irritation, itching, and redness. If these occur, it is advised to contact your healthcare provider. Rare but serious side effects such as chest pain, shortness of breath, and leg swelling should be treated as medical emergencies and require immediate attention.
If you have any questions or concerns about this formulation, please do not hesitate to reach out to your healthcare provider or pharmacist for further information and guidance.
This topical gel is a compounded formulation of estriol and estradiol, each present in a 50/50 ratio, with concentrations ranging from 0.05-0.5 mg/gm. Additionally, it contains progesterone in concentrations of 5-50 mg/gm. This unique combination is designed to address a variety of health conditions, including menopausal symptoms, endometriosis, and uterine fibroids.
Upon application to the skin, the estriol and estradiol components are absorbed into the bloodstream. These hormones work to alleviate menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. The progesterone component of the gel serves to mitigate the risk of endometrial hyperplasia, a condition that can arise when estrogen levels are excessively high. Furthermore, progesterone aids in reducing the symptoms associated with endometriosis and uterine fibroids.
When utilizing this formulation, adherence to the instructions provided by your healthcare provider is crucial. The gel is typically applied to the skin once or twice daily, depending on the severity of the symptoms. It is essential to apply the gel to clean, dry skin, and to avoid contact with the eyes, nose, and mouth. Washing your hands after applying the gel is also recommended.
If you have any queries regarding this formulation or its application, please do not hesitate to contact us.
This is a compounded formulation of Estriol, Estradiol, and Progesterone in a semisolid gel form. It is dispensed through a pump mechanism for easy and precise application on the skin.
The pump mechanism allows for easy and precise dispensing of the gel. It ensures that the correct amount of medication is applied each time, reducing the risk of over or under-dosing.
You should apply this gel directly to your skin as directed by your healthcare provider. The pump mechanism allows for easy and precise application.
The gel-like consistency allows for targeted treatment or absorption of the active ingredients. It is designed to adhere to the skin and deliver the medication directly to the affected area.
The active ingredients in this formulation are Estriol, Estradiol, and Progesterone. These are hormones that are commonly used in hormone replacement therapy.
The concentration of Estriol and Estradiol is 50% each, ranging from 0.05 to 0.5 mg per gram. The concentration of Progesterone ranges from 5 to 50 mg per gram.
As with any medication, there may be potential side effects. These can include skin irritation at the application site, changes in mood or weight, and others. Always consult your healthcare provider for a complete list of potential side effects.
It is important to consult your healthcare provider before using this medication if you are pregnant or breastfeeding. They will be able to provide you with the most accurate and up-to-date information.
This medication should be stored at room temperature, away from heat and direct light. Keep it out of reach of children and pets.
If you miss a dose, apply it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)